摘要
目的观察肾衰Ⅱ号方对慢性肾衰竭大鼠有氧糖酵解及肾间质纤维化的影响,探讨其抗肾间质纤维化的作用机制。方法体内实验以5/6(A/I)手术构建慢性肾衰竭大鼠模型,随机分为假手术组、模型组、中药组、西药组,进行相应干预8周后,取肾组织行PAS染色观察肾脏病理变化,Western blot检测α-平滑肌肌动蛋白(α-SMA)蛋白表达,免疫组化检测α-SMA、己糖激酶(HK)2蛋白定位,紫外法检测肾组织HK活性,比色法检测肾组织乳酸、丙酮酸浓度;体外实验以白细胞介素(IL)-1β刺激大鼠肾成纤维细胞NRK-49F构建NRK-49F增殖活化模型,细胞分为空白组、IL-1β组、IL-1β+肾衰Ⅱ号方低剂量组(200μg/mL)、IL-1β+肾衰Ⅱ号方高剂量组(400μg/mL)、IL-1β+2-脱氧-D-葡萄糖组(10 mmol/L),Western blot检测NRK-49F细胞α-SMA、增殖细胞核抗原(PCNA)、纤维连接蛋白(FN)、HK2蛋白表达,比色法检测细胞培养基乳酸浓度,葡萄糖氧化酶法检测细胞培养基葡萄糖浓度,免疫荧光检测HK2蛋白表达。结果体内实验:与假手术组比较,模型组PAS染色提示肾间质糖原含量增加,肾小球、肾小管形态异常;α-SMA蛋白表达明显升高(P<0.01),肾组织乳酸浓度、乳酸/丙酮酸、HK活性、HK2蛋白表达均明显升高(P<0.01)。与模型组比较,中药组和西药组肾组织病理变化改善,α-SMA蛋白表达、乳酸浓度、乳酸/丙酮酸、HK活性、HK2蛋白表达均明显降低(P<0.05,P<0.01)。体外实验:与空白组比较,IL-1β组NRK-49F细胞FN、α-SMA、PCNA、HK2蛋白表达明显升高(P<0.05,P<0.01);细胞培养基pH值、葡萄糖浓度明显降低(P<0.05),乳酸浓度明显升高(P<0.01);与IL-1β组比较,各干预组NRK-49F细胞FN、α-SMA、PCNA、HK2蛋白表达明显降低(P<0.05,P<0.01);细胞培养基pH值、葡萄糖浓度升高(P<0.05,P<0.01),乳酸浓度明显降低(P<0.01)。结论肾衰Ⅱ号方可通过抑制NRK-49F细胞有氧糖酵解反应,从而阻止成纤维细胞增殖活化,实现其抗肾间质纤维化的作用。
Objective To observe the effects of ShenshuaiⅡPrescription on aerobic glycolysis and renal interstitial fibrosisin rats with chronic renal failure;To explore its anti-renal fibrosis mechanism.Methods In vivo experiment,the rat model of chronic renal failure was established by 5/6(A/I)operation.The rats were divided into sham-operation group,model group,TCM group and Western medicine group.After 8 weeks of intervention,renal tissue was taken for PAS staining to observe the pathological changes of kidney;Western blot was used to detect the expression ofα-smooth muscle actin(α-SMA)protein;immunohistochemistry was used to detect the protein localization ofα-SMA and hexokinase(HK)2;the activity of HK in renal tissue was detected by UV;the concentration of lactic acid and pyruvate in renal tissue was measured by colorimetry.In vitro experiment,the proliferation and activation model of NRK-49F was established by stimulating rat renal fibroblasts NRK-49F with interleukin(IL)-1β.The cells were divided into blank group,IL-1β group,IL-1β+low dosage of Shenshuai Ⅱ Recipe group(200μg/mL)and IL-1β+high dosage of Shenshuai Ⅱ Recipe group(400μg/mL),IL-1β+2-deoxy-D-glucose group(10 mmol/L).The protein expression ofα-SMA,proliferating cell nuclear antigen(PCNA),fibronectin(FN)and HK2 in NRK-49F cells were detected by Western blot;the concentration of lactic acid in cell medium was detected by colorimetry;the glucose concentration in cell medium was detected by glucose oxidase method;the expression of HK2 protein was detected by immunocytofluorescence.Results Vivo experiment showed that,compared with the sham-operation group,the PAS staining in the model group indicated that the interstitial glycogen content increased,the morphology of glomerulus and renal tubule was abnormal,the expression ofα-SMA protein increased(P<0.01),and the concentration of lactic acid,lactic acid/pyruvate,HK activity and HK2 protein expression in renal tissue increased(P<0.01).Compared with the model group,the pathological changes of renal tissue in the TCM group and the Western medicine group were improved,and the expressions ofα-SMA protein,lactic acid concentration,lactic acid/pyruvate,HK activity and HK2 protein expressions decreased in the TCM group and Western medicine group(P<0.05,P<0.01).Vitro experiment showed that,compared with the blank group,the protein expressions of FN,α-SMA,PCNA and HK2 in NRK-49F cells of the IL-1β group increased(P<0.05,P<0.01),the pH value of culture medium and the concentration of glucose decreased(P<0.05),and the concentration of lactic acid increased(P<0.01).Compared with the model group,the protein expressions of FN,α-SMA,PCNA and HK2 in each intervention group decreased(P<0.05,P<0.01),the pH value of culture medium and the concentration of glucose increased(P<0.05,P<0.01),and the concentration of lactic acid decreased(P<0.01).Conclusion Shenshuai Ⅱ Prescription may inhibit the aerobic glycolysis of NRK-49F cells to prevent the proliferation and activation of fibroblasts and achieve its anti-renal fibrosis effect.
作者
杨柳易
王蒙
周圆
王琛
YANG Liuyi;WANG Meng;ZHOU Yuan;WANG Chen(Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,TCM Institute of Kidney Disease,Shanghai University of Traditional Chinese Medicine,Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Shanghai 201203,China)
出处
《中国中医药信息杂志》
CAS
CSCD
2021年第10期57-63,共7页
Chinese Journal of Information on Traditional Chinese Medicine
基金
国家自然科学基金(81973770)
上海市进一步加快中医药事业发展三年行动计划(ZY-(2018-2020)-FWTX-7005)
上海中医药大学“研究生创新培养专项”(Y2020006)。
关键词
肾衰Ⅱ号方
肾间质纤维化
有氧糖酵解
肾成纤维细胞
大鼠
Shenshuai Ⅱ Recipe
renal interstitial fibrosis
aerobic glycolysis
renal fibroblasts
rats